Breaking News Instant updates and real-time market news.

2021-02-22 09:16:31 HCDI Harbor Custom Development $3.66 / -0.17 (-4.44%) , LEN Lennar $87.44 / +1.06 (+1.23%) 09:16 02/22/21 02/22 09:16 02/22/21 09:16	Harbor Custom Development to sell 99 lots in Soundview Estates to Lennar Harbor Custom Development (HCDI) announced that it has entered into a purchase and sale agreement with Lennar Northwest, Inc., a subsidiary of Lennar Corporation (LEN), to sell 99 undeveloped lots in phase 7 of Soundview Estates in Bremerton, Washington for $7,920,000. The closing of the sale is scheduled for March 29, 2021. Harbor has now announced the completion of infrastructure improvements on 215 lots at Soundview Estates, of which Lennar purchased 165 lots for single-family home construction. Lennar also previously contracted to purchase 50 developed lots in phase 6 of Soundview Estates for $7,000,000 with a closing date of March 25, 2021. The combined first quarter scheduled sales to Lennar now total $14,920,000. With the addition of phase 7, Soundview Estates will grow to a 339-lot subdivision offering spectacular views of the Olympic Mountains, Mt. Rainier, the Seattle Skyline, and the Puget Sound. Soundview Estates is less than a ten-minute drive to the Seattle Ferry and the Kitsap Naval Shipyard. HCDI Harbor Custom Development $3.66 / -0.17 (-4.44%) LEN Lennar $87.44 / +1.06 (+1.23%)	07 Aug 13 Jan
HCDI LEN HCDI Harbor Custom Development $3.66 / -0.17 (-4.44%) LEN Lennar $87.44 / +1.06 (+1.23%) 12/29/20 Keefe Bruyette Lennar positioned for 'promising' 2021, says Keefe Bruyette 12/21/20 Citi Lennar price target raised to $100 from $90 at Citi 12/21/20 Argus Lennar price target raised to $100 from $88 at Argus 12/18/20 BTIG Lennar price target raised to $104 from $99 at BTIG

2021-02-22 09:16:31

HCDI

Harbor Custom Development

$3.66 / -0.17 (-4.44%)

, LEN

Lennar

$87.44 / +1.06 (+1.23%)

09:16

02/22/21

02/22

09:16

02/22/21

09:16

Harbor Custom Development to sell 99 lots in Soundview Estates to Lennar

Harbor Custom Development (HCDI) announced that it has entered into a purchase and sale agreement with Lennar Northwest, Inc., a subsidiary of Lennar Corporation (LEN), to sell 99 undeveloped lots in phase 7 of Soundview Estates in Bremerton, Washington for $7,920,000. The closing of the sale is scheduled for March 29, 2021. Harbor has now announced the completion of infrastructure improvements on 215 lots at Soundview Estates, of which Lennar purchased 165 lots for single-family home construction. Lennar also previously contracted to purchase 50 developed lots in phase 6 of Soundview Estates for $7,000,000 with a closing date of March 25, 2021. The combined first quarter scheduled sales to Lennar now total $14,920,000. With the addition of phase 7, Soundview Estates will grow to a 339-lot subdivision offering spectacular views of the Olympic Mountains, Mt. Rainier, the Seattle Skyline, and the Puget Sound. Soundview Estates is less than a ten-minute drive to the Seattle Ferry and the Kitsap Naval Shipyard.

HCDI

Harbor Custom Development

$3.66 / -0.17 (-4.44%)

LEN

Lennar

$87.44 / +1.06 (+1.23%)

07
Aug
13
Jan

HCDI
LEN

HCDI Harbor Custom Development

$3.66 / -0.17 (-4.44%)

LEN Lennar

$87.44 / +1.06 (+1.23%)

12/29/20 Keefe Bruyette: Lennar positioned for 'promising' 2021, says Keefe Bruyette

12/21/20 Citi: Lennar price target raised to $100 from $90 at Citi

12/21/20 Argus: Lennar price target raised to $100 from $88 at Argus

12/18/20 BTIG: Lennar price target raised to $104 from $99 at BTIG

TODAY'S FREE FLY STORIES

Recommendations	Tervita price target raised to C$4.50 from C$4 at CIBC » 11:38 03/08/21 03/08 11:38 03/08/21 11:38 TRVCF Tervita $0.00 / + (+0.00%) CIBC analyst Dave… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TRVCF Tervita $0.00 / + (+0.00%) 10:55 Today National Bank Tervita price target raised to C$4.50 from C$3.50 at National Bank 01/27/21 National Bank Tervita price target raised to C$3.50 from C$2.50 at National Bank 01/19/21 CIBC Tervita initiated with a Neutral at CIBC 12/18/20 BMO Capital Tervita price target lowered to C$4.50 from C$5 at BMO Capital
Recommendations	Parkland price target raised to C$49 from C$48 at CIBC » 11:37 03/08/21 03/08 11:37 03/08/21 11:37 PKIUF Parkland $0.00 / + (+0.00%) CIBC analyst Kevin Chiang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research PKIUF Parkland $0.00 / + (+0.00%) 02/26/21 Parkland to acquire Conrad & Bischoff, terms not disclosed PKIUF Parkland $0.00 / + (+0.00%) 10:51 Today Scotiabank Parkland price target lowered to C$50 from C$52 at Scotiabank 02/23/21 CIBC Parkland price target lowered to C$48 from C$51 at CIBC 02/23/21 National Bank Parkland price target lowered to C$44 from C$46 at National Bank 01/08/21 TD Securities Parkland price target raised to C$50 from C$46 at TD Securities
Recommendations	Winpak price target lowered to C$43 from C$44 at RBC Capital » 11:36 03/08/21 03/08 11:36 03/08/21 11:36 WIPKF Winpak $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WIPKF Winpak $0.00 / + (+0.00%) 09/18/20 CIBC CIBC upgrades Winpak to Outperformer on muted COVID impact 09/18/20 CIBC Winpak upgraded to Outperformer from Neutral at CIBC 05/06/20 TD Securities Winpak price target raised to C$48 from C$45 at TD Securities 05/06/20 Scotiabank Winpak price target raised to C$53 from C$51 at Scotiabank
Recommendations	Tricon Residential price target raised to C$14.50 from C$14 at RBC Capital » 11:35 03/08/21 03/08 11:35 03/08/21 11:35 TCNGF Tricon Residential $0.00 / + (+0.00%) RBC Capital analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TCNGF Tricon Residential $0.00 / + (+0.00%) 10:53 Today Scotiabank Tricon Residential price target raised to C$15 from C$14 at Scotiabank 03/05/21 BMO Capital Tricon Residential price target raised to C$15 from C$14 at BMO Capital 03/05/21 TD Securities Tricon Residential price target raised to C$14.50 from C$13.50 at TD Securities 01/28/21 Canaccord Tricon Residential price target raised to C$14.25 from C$13 at Canaccord
Recommendations	Tamarack Valley Energy price target raised to C$3.25 from C$3 at RBC Capital » 11:35 03/08/21 03/08 11:35 03/08/21 11:35 TNEYF Tamarack Valley Energy $0.00 / + (+0.00%) RBC Capital analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events TNEYF Tamarack Valley Energy $0.00 / + (+0.00%) 03/03/21 Desjardins Tamarack Valley Energy price target raised to C$3 from C$2.25 at Desjardins 03/02/21 BMO Capital Tamarack Valley Energy price target raised to C$2.25 from C$1.75 at BMO Capital 03/02/21 RBC Capital Tamarack Valley Energy price target raised to C$3 from C$2.75 at RBC Capital 03/02/21 Stifel Tamarack Valley Energy price target raised to C$3 from C$2.25 at Stifel 04/06/21 Capp Energy Virtual Symposium

Hot Stocks	NIH starts enrolling third trial of blood clotting treatments for COVID-19 » 11:35 03/08/21 03/08 11:35 03/08/21 11:35 BMY Bristol-Myers $61.06 / +0.63 (+1.04%) , PFE Pfizer $34.74 / +0.36 (+1.05%) The National Institutes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 02/26/21 Bristol-Myers receives positive CHMP opinion for Opdivo/Cabometyx combination 02/24/21 Bluebird Bio, Bristol-Myers' KarMMa study meets primary endpoint, NEJM reports 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/22/21 Compugen expands clinical collaboration agreement with Bristol-Myers PFE Pfizer $34.74 / +0.36 (+1.05%) 03/03/21 FDA expands approval of Pfizer's Lorbrena 03/02/21 Strata Oncology starts trial with Pfizer as partner 03/01/21 Flowserve supports Pfizer in production of COVID-19 vaccine 02/26/21 Pfizer: EMA accepts MAA for 20-valent pneumococcal conjugate vaccine candidate BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 05:59 Today BofA Gartner added to US 1 List, Bristol-Myers removed at BofA 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley 02/02/21 BTIG Prothena upgraded to Buy at BTIG on birtamimab 'revival' 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair PFE Pfizer $34.74 / +0.36 (+1.05%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/03/21 Mizuho Pfizer price target lowered to $42 from $44 at Mizuho BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 PFE Pfizer $34.74 / +0.36 (+1.05%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports PFE Pfizer $34.74 / +0.36 (+1.05%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 11/05/20 Fly Intel: Pre-market Movers PFE Pfizer $34.74 / +0.36 (+1.05%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 03/24/21 Arthritis Advisory Committee and Drug Safety & Risk Mgmt Committee Meeting 03/27/21 PDUFA Date for Ide-Cel 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 BMY PFE BMY Bristol-Myers $61.06 / +0.63 (+1.04%) 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish 01/04/21 Bristol Myers Squibb call buyer realizes 25% same-day gains PFE Pfizer $34.74 / +0.36 (+1.05%) 03/04/21 Pfizer call volume above normal and directionally bullish 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th
Recommendations	Recipe Unlimited price target raised to C$19 from C$14 at RBC Capital » 11:34 03/08/21 03/08 11:34 03/08/21 11:34 RCPUF Recipe Unlimited $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RCPUF Recipe Unlimited $0.00 / + (+0.00%) 11:18 Today BMO Capital Recipe Unlimited price target raised to C$17.50 from C$13 at BMO Capital 10:53 Today Scotiabank Recipe Unlimited price target raised to C$21 from C$18.50 at Scotiabank 05/13/20 Scotiabank Recipe Unlimited price target lowered to C$14 from C$15.50 at Scotiabank 05/11/20 CIBC Recipe Unlimited price target lowered to C$12 from C$13 at CIBC
Recommendations	Granite Real Estate price target raised to C$84 from C$82 at RBC Capital » 11:33 03/08/21 03/08 11:33 03/08/21 11:33 GRP Granite Real Estate $0.00 / + (+0.00%) RBC Capital analyst Pammi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GRP Granite Real Estate $0.00 / + (+0.00%) 10:59 Today Desjardins Granite Real Estate price target lowered to C$84 from C$85 at Desjardins 03/05/21 BMO Capital Granite Real Estate price target raised to C$85 from C$83 at BMO Capital
Recommendations	Ensign Energy price target raised to C$1.75 from C$1.50 at RBC Capital » 11:33 03/08/21 03/08 11:33 03/08/21 11:33 ESVIF Ensign Energy $0.00 / + (+0.00%) RBC Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ESVIF Ensign Energy $0.00 / + (+0.00%) 11:17 Today BMO Capital Ensign Energy price target raised to C$1.50 from C$1.25 at BMO Capital 01/19/21 CIBC Ensign Energy initiated with a Neutral at CIBC 01/12/21 Raymond James Ensign Energy upgraded to Outperform from Market Perform at Raymond James 01/04/21 BMO Capital Ensign Energy price target raised to C$1.00 from C$0.65 at BMO Capital
Conference/Events	DraftKings to host virtual investor day » 11:31 03/08/21 03/08 11:31 03/08/21 11:31 DKNG DraftKings $61.72 / +2.02 (+3.38%) Virtual Investor day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DKNG DraftKings $61.72 / +2.02 (+3.38%) 03/04/21 DraftKings becomes 'Official Sportsbook, Daily Fantasy Partner' of UFC 03/03/21 Dish, DraftKings announce strategic agreement 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering DKNG DraftKings $61.72 / +2.02 (+3.38%) 03/01/21 Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 03/01/21 Canaccord DraftKings price target raised to $80 from $65 at Canaccord 03/01/21 Northland DraftKings price target raised to $70 from $55 at Northland 03/01/21 Benchmark DraftKings price target raised to $69 from $66 at Benchmark DKNG DraftKings $61.72 / +2.02 (+3.38%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 07 Oct 19 Jun DKNG DraftKings $61.72 / +2.02 (+3.38%) 03/02/21 Hedgeye adds DraftKings as a Best Idea Short 03/02/21 Connecticut, Mohegan Tribe reach deal on sports betting, The Day reports 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says DKNG DraftKings $61.72 / +2.02 (+3.38%) 03/05/21 Bet On It: Connecticut and South Dakota inch closer to legal sports betting 03/04/21 Fly Intel: Pre-market Movers 03/01/21 Fly Intel: Wall Street's top stories for Monday 02/26/21 Fly Intel: Wall Street's top stories for Friday 03/09/21 DraftKings Inc DKNG DraftKings $61.72 / +2.02 (+3.38%) 10:25 Today DraftKings call volume above normal and directionally bullish 02/02/21 DraftKings call volume above normal and directionally bullish 01/27/21 DraftKings call volume above normal and directionally bullish 01/26/21 DraftKings call volume above normal and directionally bullish

Options	Nano Dimension call volume above normal and directionally bullish » 11:25 03/08/21 03/08 11:25 03/08/21 11:25 NNDM Nano Dimension $8.80 / +1.19 (+15.64%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events Options NNDM Nano Dimension $8.80 / +1.19 (+15.64%) 02/11/21 Nano Dimension to establish AME ACADEMY with industry suppliers 02/02/21 Nano Dimension engages CarlSquare for European acquisition search 01/25/21 Nano Dimension trading resumes 01/25/21 Nano Dimension trading halted, volatility trading pause NNDM Nano Dimension $8.80 / +1.19 (+15.64%) 02/09/21 Nano Dimension sees 2020 revenue $3.4M, one est. $2.43M 11/12/20 Nano Dimension reports Q2 EPS (45c), one est. (8c) NNDM Nano Dimension $8.80 / +1.19 (+15.64%) 02/16/21 Fly Intel: Pre-market Movers 01/14/21 Fly Intel: Pre-market Movers 03/11/21 Nano Dimension - NNDM NNDM Nano Dimension $8.80 / +1.19 (+15.64%) 02/08/21 Nano Dimension call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th 01/19/21 Nano Dimension call volume above normal and directionally bullish 01/13/21 Nano Dimension call volume above normal and directionally bullish
General news	European Fixed Income Summary: » 11:25 03/08/21 03/08 11:25 03/08/21 11:25 European Fixed Income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	European Commission approves Microsoft's ZeniMax acquisition » 11:20 03/08/21 03/08 11:20 03/08/21 11:20 MSFT Microsoft $232.20 / +0.6 (+0.26%) The European Commission… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $232.20 / +0.6 (+0.26%) 09:04 Today Intel, Microsoft to collaborate on DARPA program 03/07/21 Fly Intel: Top five weekend stock stories 03/05/21 Adaptive Biotechnologies says FDA issues EUA for T-Detect COVID 03/04/21 Verb Technology readies for release of Microsoft Outlook integration MSFT Microsoft $232.20 / +0.6 (+0.26%) 10:20 Today BofA BofA says buy AMD and Nvidia as Steam data points to GPU upgrade tailwinds 09:55 Today Fly Intel: Top five analyst upgrades 07:33 Today Morgan Stanley Software industry rating raised to Attractive from In-Line at Morgan Stanley 06:53 Today Goldman Sachs Microsoft upgraded to Conviction Buy from Buy at Goldman Sachs MSFT Microsoft $232.20 / +0.6 (+0.26%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B MSFT Microsoft $232.20 / +0.6 (+0.26%) 03/07/21 Evolv going public in $1.7B SPAC merger, WSJ reports 03/07/21 White House urges action despite Microsoft patch amid active threat, Reuters says 03/05/21 30K U.S. groups hacked via Microsoft email software flaws, KrebsOnSecurity says 03/05/21 Take-Two CEO says players 'ready for $70 games,' VGC reports MSFT Microsoft $232.20 / +0.6 (+0.26%) 11:08 Today Microsoft, Salesforce rise as analysts get more bullish on software sector 10:06 Today Microsoft, Target upgrades among today's top calls on Wall Street 03/04/21 Fly Intel: What to watch in Slack earnings report 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 03/10/21 2nd Annual Enterprise Comms Virtual Summit 10:00 Today Microsoft - MSFT MSFT Microsoft $232.20 / +0.6 (+0.26%) 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th
Conference/Events	SPX Corporation management to meet virtually with Oppenheimer » 11:20 03/08/21 03/08 11:20 03/08/21 11:20 SPXC SPX Corporation $57.31 / +1.68 (+3.02%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SPXC SPX Corporation $57.31 / +1.68 (+3.02%) 11/12/20 SPX Corporation acquires Sensors & Software, terms not disclosed SPXC SPX Corporation $57.31 / +1.68 (+3.02%) 12/21/20 Oppenheimer SPX Corporation price target raised to $60 from $54 at Oppenheimer 09/03/20 William Blair SPX Corporation upgraded to Outperform from Market Perform at William Blair 04/02/20 UBS UBS upgrades SPX Corp, Johnson Controls, Lennox on sooner HVAC recovery 04/02/20 UBS SPX Corporation upgraded to Buy from Neutral at UBS SPXC SPX Corporation $57.31 / +1.68 (+3.02%) 02/23/21 SPX Corporation reports Q4 EPS 89c, consensus 94c 10/29/20 SPX Corporation sees 2020 earnings 'modestly higher' than 2019 10/29/20 SPX Corporation reports Q3 adjusted EPS 64c, consensus 50c 03/09/21 SPX Corporation
Recommendations	SNC-Lavalin price target raised to C$28 from C$24 at BMO Capital » 11:19 03/08/21 03/08 11:19 03/08/21 11:19 SNCAF SNC-Lavalin $0.00 / + (+0.00%) BMO Capital analyst Devin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SNCAF SNC-Lavalin $0.00 / + (+0.00%) 02/10/21 RBC Capital SNC-Lavalin price target raised to C$33 from C$32 at RBC Capital 02/10/21 Scotiabank SNC-Lavalin price target raised to C$42 from C$38 at Scotiabank 02/10/21 TD Securities SNC-Lavalin price target raised to C$33 from C$31 at TD Securities 01/14/21 CIBC SNC-Lavalin price target raised to C$31 from C$30 at CIBC

Recommendations	Surge Energy price target raised to C$0.75 from C$0.45 at BMO Capital » 11:18 03/08/21 03/08 11:18 03/08/21 11:18 ZPTAF Surge Energy $0.00 / + (+0.00%) BMO Capital analyst Ray… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ZPTAF Surge Energy $0.00 / + (+0.00%) 07:52 Today Stifel Surge Energy upgraded to Buy from Hold at Stifel 03/07/21 National Bank Surge Energy upgraded to Outperform from Sector Perform at National Bank 02/19/21 National Bank Surge Energy price target raised to C$0.75 from C$0.50 at National Bank 01/28/21 Stifel Surge Energy price target raised to C$0.45 from C$0.40 at Stifel
Recommendations	Recipe Unlimited price target raised to C$17.50 from C$13 at BMO Capital » 11:18 03/08/21 03/08 11:18 03/08/21 11:18 RCPUF Recipe Unlimited $0.00 / + (+0.00%) BMO Capital analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RCPUF Recipe Unlimited $0.00 / + (+0.00%) 10:53 Today Scotiabank Recipe Unlimited price target raised to C$21 from C$18.50 at Scotiabank 05/13/20 Scotiabank Recipe Unlimited price target lowered to C$14 from C$15.50 at Scotiabank 05/11/20 CIBC Recipe Unlimited price target lowered to C$12 from C$13 at CIBC 04/15/20 CIBC Recipe Unlimited price target lowered to C$13 from C$21 at CIBC
Recommendations	Ensign Energy price target raised to C$1.50 from C$1.25 at BMO Capital » 11:17 03/08/21 03/08 11:17 03/08/21 11:17 ESVIF Ensign Energy $0.00 / + (+0.00%) BMO Capital analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ESVIF Ensign Energy $0.00 / + (+0.00%) 01/19/21 CIBC Ensign Energy initiated with a Neutral at CIBC 01/12/21 Raymond James Ensign Energy upgraded to Outperform from Market Perform at Raymond James 01/04/21 BMO Capital Ensign Energy price target raised to C$1.00 from C$0.65 at BMO Capital 10/02/20 Raymond James Ensign Energy price target raised to C$0.55 from C$0.50 at Raymond James
Technical Analysis	NASDAQ market internals summary » 11:17 03/08/21 03/08 11:17 03/08/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 03/05/21 NASDAQ market internals summary 03/05/21 NASDAQ market internals summary 03/05/21 NASDAQ market internals summary
Recommendations	Major Drilling price target lowered to C$9 from C$9.75 at Stifel » 11:16 03/08/21 03/08 11:16 03/08/21 11:16 MJDLF Major Drilling $0.00 / + (+0.00%) Stifel analyst Maggie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MJDLF Major Drilling $0.00 / + (+0.00%) 12/14/20 RBC Capital Major Drilling price target raised to $9 from $8 at RBC Capital 12/14/20 TD Securities Major Drilling price target raised to C$8.50 from C$8 at TD Securities 09/10/20 RBC Capital Major Drilling price target raised to C$8 from C$6 at RBC Capital 09/10/20 TD Securities Major Drilling price target raised to C$8 from C$6 at TD Securities

Technical Analysis	NYSE market internals summary » 11:16 03/08/21 03/08 11:16 03/08/21 11:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 10:16 Today NYSE market internals summary 03/05/21 NYSE market internals summary 03/05/21 NYSE market internals summary 03/05/21 NYSE market internals summary
Conference/Events	Palomar management to meet virtually with JMP Securities » 11:15 03/08/21 03/08 11:15 03/08/21 11:15 PLMR Palomar $76.32 / +0.41 (+0.54%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PLMR Palomar $76.32 / +0.41 (+0.54%) 02/17/21 Palomar enters trading agreement with Technical Risk Underwriters 01/12/21 Palomar appoints Mark Brose as CTO 01/04/21 Palomar promotes Michelle Johnson to chief talent and diversity officer 11/30/20 Palomar names Angela Grant chief legal officer PLMR Palomar $76.32 / +0.41 (+0.54%) 02/23/21 Keefe Bruyette Palomar recent selloff on Uri 'very overdone,' says Keefe Bruyette 01/12/21 Barclays Palomar price target raised to $94 from $82 at Barclays 11/17/20 Barclays Palomar initiated with an Equal Weight at Barclays 11/12/20 Fly Intel: Top five analyst downgrades PLMR Palomar $76.32 / +0.41 (+0.54%) 02/24/21 Palomar reports Q4 EPS (7c), consensus 0c 11/10/20 Palomar reports Q3 EPS (62c), consensus (54c) 24 Jun PLMR Palomar $76.32 / +0.41 (+0.54%) 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Wall Street's top stories at midday 03/09/21 Palomar
Recommendations	JMP Securities remains bullish on Minerva after results, ahead of OLE results » 11:15 03/08/21 03/08 11:15 03/08/21 11:15 NERV Minerva $3.16 / +0.275 (+9.53%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NERV Minerva $3.16 / +0.275 (+9.53%) 07:35 Today Minerva expects data from OLE phase of Phase 3 trial of roluperidone in 1H21 01/19/21 Royalty Pharma acquires royalty interest in Seltorexant from Minerva 01/19/21 Minerva, Royalty Pharma announce sale of seltorexant royalty for up to $155M 12/01/20 Minerva announces outcomes of Type C meeting with FDA on roluperidone NERV Minerva $3.16 / +0.275 (+9.53%) 12/01/20 JMP Securities Minerva laid out path to roluperidone submission, says JMP Securities 07/01/20 JMP Securities Minerva's seltorexant still 'underappreciated' upside driver, says JMP 06/08/20 H.C. Wainwright Minerva price target lowered to $10 from $20 at H.C. Wainwright 06/05/20 JMP Securities Minerva reinstated with an Outperform at JMP Securities NERV Minerva $3.16 / +0.275 (+9.53%) 07:32 Today Minerva reports Q4 EPS (17c), consensus (19c) 11/02/20 Minerva reports Q3 EPS (19c), consensus (23c) 08:30 Today Minerva - NERV
Recommendations	Freehold Royalties price target raised to C$8.50 from C$7 at Raymond James » 11:15 03/08/21 03/08 11:15 03/08/21 11:15 FRHLF Freehold Royalties $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events FRHLF Freehold Royalties $0.00 / + (+0.00%) 03/05/21 RBC Capital Freehold Royalties price target raised to C$10 from C$9 at RBC Capital 03/05/21 BMO Capital Freehold Royalties price target raised to C$9 from C$6 at BMO Capital 03/05/21 Scotiabank Freehold Royalties price target raised to C$8 from C$7.25 at Scotiabank 03/05/21 TD Securities Freehold Royalties price target raised to C$9.50 from C$9 at TD Securities 04/06/21 Capp Energy Virtual Symposium
General news	6-Month Bill Auction to be released at 11:30 11:15 03/08/21 03/08 11:15 03/08/21 11:15

Events

Earnings calls, analyst events, roadshows and more

NK
Today at 12:30

NantKwest, Inc. Firm Sponsored Meetings
GRPBF
Today at 13:00

Grupo Lala - GRPBF Conference Calls
ADVM ...
Today at 13:00

Biopharmaceuticals Industry Meetings
GNRC
Today at 13:00

Electrical Equipment/Multi-Industry Industry Meetings
RAND
Today at 13:30

Rand Capital - RAND Conference Calls
Today at 14:00

Healthcare Industry Meetings
CYDY
Today at 16:00

CytoDyn - CYDY Conference Calls
PRTH
Today at 16:00

Priority Technology - PRTH Conference Calls
SMSI
Today at 16:30

Smith Micro - SMSI Conference Calls
TACO
Today at 16:30

Del Taco - TACO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

Harbor Custom Development to sell 99 lots in Soundview Estates to Lennar

TODAY'S FREE FLY STORIES

Get Full Fly Access